SLC5A2 and diabetes mellitus: This result is consistent with previous studies showing that SUA levels decrease in diabetes patients who have received an inhibitor of sodium-glucose cotransporter 2 (SGLT2) (Davies et al. 2015; van Bommel et al. 2017; Ouchi et al. 2018).